P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib

• Paiyun Li,

  Roles Conceptualization, Data curation, Investigation, Methodology, Writing – original draft

  Affiliation Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Etiology, Peking University Cancer Hospital and Institute, Beijing, China

  ⨯
• Xuehong Zhang,

  Roles Investigation

  Affiliation Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Etiology, Peking University Cancer Hospital and Institute, Beijing, China

  ⨯
• Liankun Gu,

  Roles Investigation

  Affiliation Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Etiology, Peking University Cancer Hospital and Institute, Beijing, China

  ⨯
• Jing Zhou,

  Roles Investigation

  Affiliation Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Etiology, Peking University Cancer Hospital and Institute, Beijing, China

  ⨯
• Dajun Deng

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Project administration, Supervision, Visualization, Writing – review & editing

  * E-mail: dengdajun@bjmu.edu.cn

  Affiliation Key Laboratory of Carcinogenesis and Translational Research (MOE/Beijing), Division of Etiology, Peking University Cancer Hospital and Institute, Beijing, China

  http://orcid.org/0000-0001-5161-5943

  ⨯